Particle Sciences Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Particle Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014178
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Particle Sciences Inc (Particle Sciences), a subsidiary of The Lubrizol Corp is a contract research organization that offers complete formulation, analytic, bioanalytic and clinical trial material manufacturing solutions. The organization concentrates on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including gels, emulsions, drug or device combination products, micro and nano-particulates, and solid solutions, among others. Particle Sciences serves clients including privately-backed start-ups, foundations, governments, universities, hospitals and pharmaceutical and biotech companies. The organization also has proprietary drug delivery platforms for the preformulation and formulation of drugs as well as technology platform for drug combination. Particle Sciences is headquartered in Bethlehem, Pennsylvania, the US.

Particle Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Particle Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Particle Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
Particle Sciences Enters Into Co-Development Agreement With Actavis 12
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 13
Particle Sciences Enters Into An Agreement With Absorption Systems 14
Hovione Enters Into Co-Development Agreement With Particle Sciences 15
Licensing Agreements 16
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 16
Acquisition 17
Lubrizol Acquires Particle Sciences 17
Particle Sciences Inc – Key Competitors 18
Particle Sciences Inc – Key Employees 19
Particle Sciences Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Other Significant Developments 21
May 31, 2016: Particle Sciences, a part of Lubrizol LifeSciences, Adds Sterile Powder Filling and Capsule Filling Capabilities 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Particle Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Particle Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Particle Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Particle Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
Particle Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
Particle Sciences Enters Into Co-Development Agreement With Actavis 12
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 13
Particle Sciences Enters Into An Agreement With Absorption Systems 14
Hovione Enters Into Co-Development Agreement With Particle Sciences 15
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 16
Lubrizol Acquires Particle Sciences 17
Particle Sciences Inc, Key Competitors 18
Particle Sciences Inc, Key Employees 19

★海外企業調査レポート[Particle Sciences Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mallinckrodt plc:企業の戦略・SWOT・財務分析
    Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report Summary Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • M3 Midstream LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary M3 Midstream LLC (Momentum) is an independent oil and gas company that offers midstream oilfield services. The company provides services such as gas processing and treating, wellhead gathering, dehydration, fractionation, compression, and storage services for natural gas and natural gas liqu …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Indraprastha Gas Ltd (IGL):企業の財務・戦略的SWOT分析
    Summary Indraprastha Gas Ltd (IGL) is an oil and gas company that supplies natural gas. The company offers piped natural gas, liquefied natural gas, R-LNG and compressed natural gas for industrial and commercial usage. IGL compressed natural gas is used for transportation. The company's piped natura …
  • Ambac Financial Group Inc (AMBC):企業の財務・戦略的SWOT分析
    Ambac Financial Group Inc (AMBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Brasfield & Gorrie LLC:企業の戦略・SWOT・財務分析
    Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report Summary Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Activision Blizzard, Inc.:企業の戦略・SWOT・財務情報
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Iluka Resources Ltd:企業の戦略・SWOT・財務情報
    Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Iluka Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ICON Health & Fitness, Inc.:企業の戦略・SWOT・財務情報
    ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICON Health & Fitness, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Blackstone Group LP:企業のM&A・事業提携・投資動向
    The Blackstone Group LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Blackstone Group LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Sidi Kerir Petrochemicals Co (SKPC):企業の財務・戦略的SWOT分析
    Summary Sidi Kerir Petrochemicals Co (Sidpec), a subsidiary of Egyptian Petrochemicals Holding Co, is a chemical company that manufactures and distributes petrochemical products. The company offers high density polyethylene and linear low density polyethylene which are used in plastic applications. …
  • Petrolina (Holdings) Public Ltd (PHL):企業の財務・戦略的SWOT分析
    Petrolina (Holdings) Public Ltd (PHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • GTx Inc (GTXI):製薬・医療:M&Aディール及び事業提携情報
    Summary GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical condition …
  • Banca Carige SpA (CRG):企業の財務・戦略的SWOT分析
    Banca Carige SpA (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Gujarat Industries Power Co Ltd (GIPCL):企業の財務・戦略的SWOT分析
    Gujarat Industries Power Co Ltd (GIPCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bio-Rad Laboratories Inc (BIO)-医療機器分野:企業M&A・提携分析
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops and manufactures specialty chemicals for use in biochemical, pharmaceutical and other life science research applications. The company offers a comprehensive range of reagents, apparatus, laboratory instruments, test systems, informatics systems, te …
  • Roche Diagnostics Corp:企業のM&A・事業提携・投資動向
    Roche Diagnostics Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roche Diagnostics Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆